Philippe Kolly

Reply to «Lack of evidence of an effect of Direct Acting Antivirals on the recurrence of hepatocellular carcinoma: The ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CIRVIR and CO23 CUPILT cohorts)»

Philippe Kolly, Jean‐François Dufour · Bern Open Repository and Information System (University of Bern) · 2016 · 66 citations · Full text

Medicine, Oncology, Hepatology +13

Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm

Mandy Richani, Philippe Kolly, Marina Knoepfli et al. · Annals of Hepatology · 2015 · 52 citations · Full text

Medicine, Oncology, Cancer Control +15

Effect of smoking on survival of patients with hepatocellular carcinoma

Philippe Kolly, Marina Knöpfli, Jean‐François Dufour · Liver International · 2017 · 37 citations

Medicine, Oncology, Epidemiology +14

Assessment of the Hong Kong Liver Cancer Staging System in Europe

Philippe Kolly, Helen L. Reeves, Bruno Sangro et al. · Liver International · 2015 · 31 citations

Medicine, Oncology, Clinical Classification Systems +16

FACT‐Hep increases the accuracy of survival prediction in HCC patients when added to ECOG Performance Status

Andrea Gmür, Philippe Kolly, Marina Knöpfli et al. · Liver International · 2018 · 23 citations

Medicine, Oncology, Clinical Epidemiology +15